A01 - STOMATOLOGICAL PREPARATIONS
2011
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)

ALIMENTARY TRACT AND METABOLISM
STOMATOLOGICAL PREPARATIONS
STOMATOLOGICAL PREPARATIONS
ANTIINFECTIVES FOR LOCAL ORAL TREATMENT

A01AB04

AMPHOTERICIN

P

2931G

Lozenge 10mg

40.00

MG

148,438

1,839,338

P

3306B

Lozenge 10mg

40.00

MG

3,767

45,298

A01AB03

CHLORHEXIDINE

A

21081

Mouth wash 2mg per mL (0.2%) 300mL

30.00

MG

835

-

P

4204G

Mouth wash 2mg per mL (0.2%) 300mL

30.00

MG

1,590

25,464

A01AB09

MICONAZOLE

A

13832

Oral gel 20mg per mL (2%) 20g

0.20

GM

2,685

-

A

14054

Oral gel 40mg per mL (2%) 40g

0.20

GM

2,114

-

A01AB11

NYSTATIN

P

3033P

Oral suspension 100,000 units per mL 24mL

1500.00

TE

148,521

1,636,666

P

3343Y

Oral suspension 100,000 units per mL 24mL

1500.00

TE

956

10,406

CORTICOSTEROIDS FOR LOCAL ORAL TREATMENT

A01AC01

TRIAMCINOLONE ACETONIDE with PECTIN

A

11075

Paste 1% 5gm

-

-

11,933

-

OTHER AGENTS FOR LOCAL ORAL TREATMENT

A01AD02

BENZYDAMINE HYDROCHLORIDE

P

1121B

Mouth and throat rinse 22.5mg per 15mL 500mL

-

-

3,933

83,728

P

5032W

Mouth and throat rinse 22.5mg per 15mL 500mL

-

-

190

4,221

P

5385K

Mouth and throat rinse 22.5mg per 15mL 500mL

-

-

260

6,134

A01AD02

BENZYDAMINE with CHLORHEXIDINE

A

14359

Solution 200mL

-

-

217

-

A01AD11

CHOLINE SALICYLATE with CETALKONIUM CHLORIDE

A

12855

Gel 10g 1

-

-

1,943

-

A01AD11

SALIVA SUBSTITUTE

P

4568K

Solution 25mL

-

-

385

4,253

P

4569L

Solution 100mL

-

-

683

9,695

A01AD11

VARIOUS

P

5334R

Spray 10mg per mL 100mL

-

-

173

2,332

back to top

A02 - DRUGS FOR ACID RELATED DISORDERS
2011
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)

ALIMENTARY TRACT AND METABOLISM
DRUGS FOR ACID RELATED DISORDERS
ANTACIDS
ALUMINIUM COMPOUNDS

A02AB01

ALUMINIUM HYDROXIDE

A

10038

Tablet 600mg 100

-

-

2,956

-

CALCIUM COMPOUNDS

A02AC10

CALCIUM CARBONATE with GLYCINE

P

4055K

Tablet 420mg-180mg

-

-

506

11,828

COMBS.AND COMPLEXES OF ALUMINIUM,CALCIUM AND MAGNESIUM COMPOUNDS

A02AD

ALUMINIUM HYDROXIDE with MAGNESIUM HYDROXIDE

P

2157M

Oral suspension 200mg-200mg per 5mL 500mL

-

-

89,527

1,375,886

P

4118R

Oral suspension 400mg-400mg-30mg per 5mL

-

-

1,871

41,738

A02AD

ALUMINIUM HYDROXIDE with MAGNESIUM HYDROXIDE with SIMETHICONE

A

20644

Chewable tablet 200mg-200mg-20mg 100

-

-

126

-

P

4453J

Tablet 400mg-400mg-40mg 200

-

-

1,243

55,850

A02AD

ALUMINIUM HYDROXIDE with MAGNESIUM TRISILICATE and MAGNESIUM HYDROXIDE

P

2159P

Oral suspension 250mg-120mg-120mg per 5mL

-

-

16,883

292,640

DRUGS FOR PEPTIC ULCER AND GORD

H2-RECEPTOR ANTAGONISTS

A02BA01

CIMETIDINE

P

1157X

Tablet 200mg

0.80

GM

938

12,710

P

1158Y

Tablet 400mg

0.80

GM

4,020

73,667

P

1159B

Tablet 800mg

0.80

GM

988

18,574

A02BA03

FAMOTIDINE

P

2487X

Tablet 20mg

40.00

MG

39,288

662,829

P

2488Y

Tablet 40mg

40.00

MG

49,746

890,048

A02BA04

NIZATIDINE

P

1504E

Capsules 300mg 30

0.30

GM

71,717

1,353,059

P

1505F

Capsules 150mg 30

0.30

GM

85,373

1,574,240

A02BA02

RANITIDINE HYDROCHLORIDE

P

1937Y

Effervescent tablet 150mg (base)

0.30

GM

41,009

708,025

P

1977C

Tablet 300mg (base)

0.30

GM

274,134

4,850,962

P

1978D

Tablet 150mg (base)

0.30

GM

538,072

9,265,705

P

8162N

Syrup 150mg (base) per 10mL 300mL

0.30

GM

25,325

510,769

P

8903N

Effervescent tablet 150mg (base)

0.30

GM

1,047

22,799

P

8905Q

Syrup 150mg (base) per 10mL 300mL

0.30

GM

585

15,282

PROSTAGLANDINS

A02BB01

MISOPROSTOL

P

1648R

Tablet 200ug

0.80

MG

2,046

106,026

PROTON PUMP INHIBITORS

A02BC05

ESOMEPRAZOLE

A

20665

Sachet granules 10mg 30

30.00

MG

7,264

-

P

3401B

Tablet 40mg (enteric coated) 30

30.00

MG

45,887

2,608,186

P

8600P

Tablet 20mg (enteric coated) 30

30.00

MG

4,004,220

125,045,481

P

8601Q

Tablet 40mg (enteric coated) 30

30.00

MG

2,791,158

132,488,955

P

8886Q

Tablet 20mg (enteric coated) 30

30.00

MG

130,397

4,051,301

A02BC03

LANSOPRAZOLE

P

2240X

Capsule 30mg 28

30.00

MG

3,639

107,752

P

2241Y

Capsule 30mg 28

30.00

MG

121,002

3,516,631

P

8198L

Capsule 15mg 28

30.00

MG

3,459

69,902

P

9331D

Capsule 15mg 28

30.00

MG

18,012

338,344

P

9477T

Tablet 30mg (orally disintegrating) 28

30.00

MG

12,329

348,423

P

9478W

Tablet 30mg (orally disintegrating) 28

30.00

MG

433,333

13,820,017

A02BC01

OMEPRAZOLE

P

1326T

Capsule 20mg

20.00

MG

6,794

189,891

P

1327W

Capsule 20mg

20.00

MG

181,744

6,052,848

P

8331L

Tablet 20mg (as magnesium salt) 30

20.00

MG

45,590

1,161,582

P

8332M

Tablet 10mg (as magnesium salt) 30

20.00

MG

70,823

1,604,361

P

8333N

Tablet 20mg (as magnesium salt) 30

20.00

MG

989,364

28,689,105

P

9109K

Tablet 20mg (as magnesium salt) 30

20.00

MG

34,684

974,893

P

9110L

Tablet 20mg (as magnesium salt) 30

20.00

MG

1,681,829

58,230,855

A02BC02

PANTOPRAZOLE

A

20488

Tablet (enteric coated) equivalent to 20mg 7

40.00

MG

381

-

A

20489

Tablet (enteric coated) equivalent to 20mg 14

40.00

MG

1,370

-

A

21229

Tablet (enteric coated) equivalent to 20mg 14

40.00

MG

141

-

P

8007K

Tablet (enteric coated) equivalent to 40mg

40.00

MG

394,965

11,960,309

P

8008L

Tablet (enteric coated) equivalent to 40mg

40.00

MG

3,596,247

119,982,837

P

8399C

Tablet (enteric coated) equivalent to 20mg

40.00

MG

513,893

9,518,568

P

9423Y

Sachet containing granules 40mg 30

40.00

MG

4,277

130,322

P

9424B

Sachet containing granules 40mg 30

40.00

MG

33,536

1,074,357

A02BC04

RABEPRAZOLE

A

17042

Tablet 10mg 7

20.00

MG

131

-

A

21419

Tablet 10mg 14

20.00

MG

238

-

P

8507R

Tablet 10mg 30

20.00

MG

79,844

2,873,533

P

8508T

Tablet 20mg 30

20.00

MG

2,307,116

89,389,670

P

8509W

Tablet 20mg 30

20.00

MG

239,671

8,507,492

COMBINATIONS FOR ERADICATION OF HELICOBACTER PYLORI

A02BD06

ESOMEPRAZOLE AMOXICILAN and CLARITHROMYCIN

P

8738X

Pack 14 tabs(ent coated)equiv 20mg esomeprazole

-

-

86,235

6,713,133

A02BD05

OMEPRAZOLE and CLARITHROMYCIN and AMOXYCILLIN

P

8272J

Pack 14 caps 20mg,14 tabs 500mg,28 caps 500mg

-

-

7,108

464,015

OTHER DRUGS FOR PEPTIC ULCER AND GORD

A02BX13

SODIUM ALGINATE with CALCIUM CARBONATE and SODIUM BICARBONATE

P

2014B

Oral liquid 1gm-320mg in 20mL 500mL

-

-

111,380

1,631,322

A02BX02

SUCRALFATE

P

2055E

Tablet 1g

4.00

GM

16,616

389,048

ANTIFLATULENTS

ANTIFLATULENTS

A02DA

PEPPERMINT OIL

A

13210

Capsule 0.2mL 63

-

-

778

-

back to top

A03 - DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
2011
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)

ALIMENTARY TRACT AND METABOLISM
DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS
DRUGS FOR FUNCTIONAL BOWEL DISORDERS
SYNT ANTICHOLIN,ESTERS WITH TERTIARY AMINO GROUP

A03AA04

MEBEVERINE HYDROCHLORIDE

A

12730

Tablet 135mg 30

0.30

GM

16,166

-

A

14130

Tablet 135mg 30

0.30

GM

11,045

-

P

4328T

Tablet 135mg

0.30

GM

60,233

1,809,221

SYNT ANTICHOLINERGICS,ESTERS,QUATER AMMONIUM COMPOUND

A03AB05

PROPANTHELINE

P

1953T

Tablet 15mg

60.00

MG

15,859

403,508

OTHER DRUGS FOR FUNCTIONAL BOWEL DISORDERS

A03AX13

SIMETHICONE

A

13445

Capsule 100mg 30

-

-

134

-

BELLADONNA AND DERIVATIVES PLAIN

BELLADONNA ALKALOIDS TERTIARY AMINES

A03BA01

ATROPINE

P

1089H

Injection 600ug in 1mL 10

1.50

MG

2,940

38,036

P

3453R

Injection 600ug in 1mL 10

1.50

MG

6,880

140,049

BELLADONNA ALKALOIDS SEMISYNT QUATER AMMONIUM COMPOUND

A03BB01

BUTYLSCOPOLAMINE

A

12939

Tablet 10mg 100

60.00

MG

9,964

-

A

15287

Tablet 10mg

60.00

MG

7,849

-

P

3473T

Injection 20mg in 1mL 5

60.00

MG

6,797

164,471

P

4279F

Injection 20mg in 1mL

60.00

MG

4,133

176,530

P

5317W

Injection 20mg in 1mL

60.00

MG

1,916

256,767

P

5318X

Injection 20mg in 1mL

60.00

MG

812

103,405

A03BB

HYOSCINE HYDROBROMIDE

A

10972

Ampoule 400ug 5

-

-

9,418

-

PROPULSIVES

PROPULSIVES

A03FA03

DOMPERIDONE

A

11309

Tablet 10mg 100

30.00

MG

17,576

-

P

1347X

Tablet 10mg

30.00

MG

348,065

4,423,328

A03FA01

METOCLOPRAMIDE HYDROCHLORIDE

A

11138

Tablet 10mg 100

30.00

MG

2,639

-

P

1206L

Injection 10mg in 2mL

30.00

MG

45,196

657,177

P

1207M

Tablet 10mg

30.00

MG

822,073

7,101,214

P

3476Y

Injection 10mg in 2mL

30.00

MG

28,267

366,744

P

5151D

Tablet 10mg

30.00

MG

557

4,509

back to top

A04 - ANTIEMETICS AND ANTINAUSEANTS
2011
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)

ALIMENTARY TRACT AND METABOLISM
ANTIEMETICS AND ANTINAUSEANTS
ANTIEMETICS AND ANTINAUSEANTS
SEROTONIN (5HT3) ANTAGONISTS

A04AA04

DOLASETRON MESYLATE

P

8191D

Tablet 200mg

0.20

GM

2,350

127,372

P

8192E

I.V. injection 100mg in 5mL

0.10

GM

545

18,030

A04AA02

GRANISETRON

P

5898K

Tablet 2mg (base) 2

2.00

MG

8,811

498,084

P

5899L

Concentrated injection 3mg (base) in 3mL

3.00

MG

8,950

236,723

P

8728J

Tablet 2mg (base) 2

2.00

MG

34,227

2,207,167

P

8729K

Concentrated injection 3mg (base) in 3mL

3.00

MG

38,631

1,560,739

P

8873B

Tablet 2mg (base) 5

2.00

MG

1,063

212,100

A04AA01

ONDANSETRON

P

1594X

Tablet 4mg

16.00

MG

7,083

545,130

P

1595Y

Tablet 8mg

16.00

MG

8,105

970,905

P

5471Y

Tablet (orally disintegrating) 8mg 4

16.00

MG

115

5,463

P

5967C

Tablet 4mg

16.00

MG

763

20,718

P

5968D

Tablet 8mg

16.00

MG

18,040

670,561

P

5969E

Wafer 4mg 4

16.00

MG

134

4,559

P

5970F

Wafer 8mg 4

16.00

MG

1,222

62,348

P

5972H

I.V. injection 8mg in 4mL

16.00

MG

13,443

212,150

P

8224W

Tablet 4mg

16.00

MG

15,987

607,366

P

8225X

Tablet 8mg

16.00

MG

51,457

2,722,953

P

8226Y

I.V. injection 4mg in 2mL

16.00

MG

2,420

47,031

P

8227B

I.V. injection 8mg in 4mL

16.00

MG

18,672

595,894

P

8233H

Syrup 4mg per 5mL 50mL

16.00

MG

126

15,135

P

8410P

Wafer 4mg 4

16.00

MG

35,853

1,287,731

P

8411Q

Wafer 8mg 4

16.00

MG

25,304

1,499,780

P

8412R

Wafer 4mg 10

16.00

MG

13,132

1,081,046

P

8413T

Wafer 8mg 10

16.00

MG

12,370

1,565,176

P

9441X

Syrup 4mg per 5mL 50mL 1

16.00

MG

263

26,686

A04AA05

PALONOSETRON

P

5295Q

Injection 250ug (as hydrochloride) in 5mL 1

0.25

MG

40,834

1,917,786

P

5853C

Injection 250ug (as hydrochloride) in 5mL

0.25

MG

3,493

120,157

A04AA03

TROPISETRON

P

2745L

Capsule 5mg (base)

5.00

MG

16,955

999,640

P

2746M

I.V. injection 5mg/5mL

5.00

MG

9,949

344,405

P

5986C

Capsule 5mg (base)

5.00

MG

5,200

183,453

P

5987D

I.V. injection 5mg/5mL

5.00

MG

4,342

81,530

VARIOUS ANTIEMETICS

A04AD12

APREPITANT

P

5888X

Pack 1 cap 125mg and 2 cap 80mg

95.00

MG

12,562

1,407,070

P

8808N

Pack 1 cap 125mg and 2 cap 80mg

95.00

MG

35,174

4,824,412

A04AD01

SCOPOLAMINE

A

20612

Tablet 20mg 10

60.00

MG

968

-

back to top

A05 - BILE AND LIVER THERAPY
2011
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)

ALIMENTARY TRACT AND METABOLISM
BILE AND LIVER THERAPY
BILE THERAPY
BILE ACID PREPARATIONS

A05AA02

URSODEOXYCHOLIC ACID

P

8448P

Capsule 250mg 200

0.75

GM

28,220

9,996,969

back to top

A06 - LAXATIVES
2011
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)

ALIMENTARY TRACT AND METABOLISM
LAXATIVES
LAXATIVES
SOFTENERS EMOLLIENTS

A06AA02

DOCUSATE SODIUM

A

16099

Tablet 120mg 100

0.15

GM

10,849

-

P

4200C

Tablet 50mg

0.15

GM

9,436

135,168

A06AA01

LIQUID PARAFFIN

A

10108

Oral suspension vanilla 500mL

15.00

GM

519

-

A

10120

Oral suspension strawberry 500mL

15.00

GM

156

-

A06AA

POLOXALKOL

A

10469

Drop 10% 30mL 1

-

-

1,427

-

CONTACT LAXATIVES

A06AB02

BISACODYL

A

10635

Tablet 5mg 200

10.00

MG

382

-

P

1258F

Suppositories 10mg 12

10.00

MG

3,466

62,058

P

1259G

Tablet 5mg

10.00

MG

26,841

376,477

P

1260H

Suppositories 10mg 10

10.00

MG

30,370

616,263

P

3250C

Suppositories 10mg 10

10.00

MG

595

23,485

P

5303D

Suppositories 10mg 10

10.00

MG

179

3,932

A06AB56

DOCUSATE SODIUM with SENNA

A

12753

Tablet 30

-

-

5,586

-

P

4028B

Tablet 50mg-8mg 100

-

-

15,686

226,834

P

4198Y

Tablet 50mg-8mg 90

-

-

233,283

3,899,346

A06AB06

SENNA STANDARDISED

P

4455L

Tablet 7.5mg

-

-

9,006

125,332

BULK PRODUCERS

A06AC51

ISPAGHULA COMBINATIONS

P

4416K

Oral Powder 440g

-

-

592

12,652

A06AC01

PSYLLIUM HYDROPHILIC MUCILLOID

A

11156

Powder 500g 1

7.00

GM

962

-

A

11273

Powder 500g 1

7.00

GM

390

-

P

4285M

Sachets 3.5g 30

7.00

GM

2,213

44,489

P

4419N

Oral powder(orange-flavour sugar free)315g

7.00

GM

20,359

456,491

P

4422R

Oral powder (non-flavoured) 375g

7.00

GM

11,705

261,632

A06AC53

STERCULIA with FRANGULA BARK

P

1104D

Granules 620mg-80mg per g (62%-8%) 500g

-

-

70,371

1,768,572

P

3275J

Granules 620mg-80mg per g (62%-8%) 500g

-

-

807

25,712

P

4558X

Granules 620mg-80mg per g (62%-8%) 500g

-

-

5,428

136,948

A06AC53

STERCULIA, COMBINATIONS

P

5322D

Granules 620mg-80mg per g (62%-8%) 500g

-

-

302

7,952

OSMOTICALLY ACTING LAXATIVES

A06AD11

LACTULOSE

P

3064G

Mixture 3.34g per 5mL 500mL

6.70

GM

345,133

4,789,487

P

5387M

Mixture 3.34g per 5mL 500mL 1

6.70

GM

7,360

167,243

P

5388N

Mixture 3.34g per 5mL 500mL 1

6.70

GM

1,138

32,003

A06AD11

LACTULOSE with GALACTOSE with LACTOSE with EPILACTOSE

A

10693

Syrup 200mL 1

6.70

GM

478

-

A06AD15

MACROGOL

P

3278M

Sachets powder 13.125g with electrolytes 2

10.00

GM

1,162

28,980

P

3416T

Powder for oral solution 510g

10.00

GM

34,938

719,586

P

5389P

Sachets powder 13.125g with electrolytes 30

10.00

GM

6,795

238,181

P

5390Q

Sachets powder 13.125g with electrolytes 30

10.00

GM

1,648

59,056

P

5426N

Powder for oral solution 510g

10.00

GM

242

8,085

P

8612G

Sachets powder 13.125g with electrolytes 30

10.00

GM

893,738

18,628,515

A06AD

SORBITOL

A

14787

Liquid 70% 500mL

-

-

17,224

-

ENEMAS

A06AG02

BISACODYL

P

1263L

Enemas 10mg in 5mL 25

-

-

9,608

415,704

P

3263R

Enemas 10mg in 5mL 25

-

-

3,447

191,213

P

5302C

Enemas 10mg in 5mL 25

10.00

MG

349

16,123

A06AG20

COMBINATION (SORBITOL/SODIUM CITRATE/SODIUM LAURYL SULFOACETATE)

P

2091C

Enemas 3.125g-450mg-45mg in 5mL 12

-

-

46,943

1,514,964

P

3274H

Enemas 3.125g-450mg-45mg in 5mL 12

-

-

4,309

195,042

P

4462W

Enemas 3.125g-450mg-45mg in 5mL 4

-

-

2,483

32,683

P

5331N

Enemas 3.125g-450mg-45mg in 5mL 12

-

-

1,183

42,469

P

5332P

Enemas 3.125g-450mg-45mg in 5mL 12

-

-

261

10,540

A06AG01

SODIUM PHOSPHATE

A

15629

Laxative Mixt 3.3G/5mL

-

-

677

-

PERIPHERAL OPIOID RECEPTOR ANTAGONISTS

A06AH01

METHYLNALTREXONE BROMIDE

P

5423K

Solution for injection 12mg in 0.6mL 7

6.00

MG

216

30,898

P

5424L

Solution for injection 12mg in 0.6mL 7

6.00

MG

122

44,611

OTHER LAXATIVES

A06AX01

GLYCEROL

P

2555L

Suppositories 700mg (for infants) 12

-

-

394

6,575

P

2556M

Suppositories 1.4g (for children) 12

-

-

769

14,174

P

2557N

Suppositories 2.8g (for adults) 12

-

-

9,213

172,117

P

3267Y

Suppositories 2.8g (for adults) 12

-

-

238

7,238

P

4246L

Suppositories 2.8g (for adults) 12

-

-

186

3,404

back to top

A07 - ANTIDIARR. INTEST. ANTIINFL./ANTIINFECT. AGENTS
2011
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)

ALIMENTARY TRACT AND METABOLISM
ANTIDIARR. INTEST. ANTIINFL./ANTIINFECT. AGENTS
INTESTINAL ANTIINFECTIVES
ANTIBIOTICS

A07AA01

NEOMYCIN SULPHATE

P

2325J

Tablet 500mg

5.00

GM

1,062

13,747

A07AA02

NYSTATIN

P

1696G

Tablet 500,000 units

1500.00

TE

19,975

399,729

P

1699K

Capsule 500,000 units

1500.00

TE

29,924

659,557

A07AA09

VANCOMYCIN

P

3113W

Capsule 125 mg (125,000 i.u.) vancomycin activity

2.00

GM

858

221,228

P

3114X

Capsule 250 mg (250,000 i.u.) vancomycin activity

2.00

GM

978

553,372

ELECTROLYTES WITH CARBOHYDRATES

ORAL REHYDRATION SALT FORMULATIONS

A07CA

ELECTROLYTE REPLACEMENT (ORAL)

P

3196F

Sachets of powder for oral solution 4.87g 10

-

-

23,754

370,773

ANTIPROPULSIVES

ANTIPROPULSIVES

A07DA01

DIPHENOXYLATE HYDROCHLORIDE with ATROPINE SULPHATE

A

11123

Tablet 2.5mg-25ug 100

15.00

MG

1,319

-

A

16260

Tablet 2.5mg-25ug 8

15.00

MG

1,658

-

P

2501P

Tablet 2.5mg-25ug

15.00

MG

223,401

2,257,444

A07DA03

LOPERAMIDE HYDROCHLORIDE

P

1571Q

Capsule 2mg

10.00

MG

255,518

4,143,511

A

16133

Tablet 2mg 8

10.00

MG

163

-

INTESTINAL ANTIINFLAMMATORY AGENTS

CORTICOSTEROIDS FOR LOCAL USE

A07EA02

HYDROCORTISONE ACETATE

P

1502C

Rectal foam 125mg per applicator (10%) aerosol

-

-

11,434

429,097

A07EA01

PREDNISOLONE SODIUM PHOSPHATE

P

1920C

Retention enema equivalent to 20mg prednisolone

-

-

5,303

1,090,194

P

2554K

Suppositories equivalent to 5mg prednisolone 10

-

-

7,914

327,539

AMINOSALICYLIC ACID AND SIMILAR AGENTS

A07EC04

BALSALAZIDE

P

8845M

Capsule 750mg

6.75

GM

22,856

3,227,643

A07EC02

MESALAZINE

P

1611T

Tablet 250mg

1.50

GM

51,054

8,102,603

P

2214M

Tablet 500mg (prolonged release) 200

1.50

GM

7,413

2,146,218

P

2234N

Oral granules (prolonged release) 1g per sachet 100

1.50

GM

2,507

782,813

P

2287J

Oral granules (prolonged release) 2g per sachet 60

1.50

GM

14,454

4,555,558

P

3413P

Tablet 1g (prolonged release) 120

1.50

GM

6,308

2,030,875

P

5461K

Suppository (moulded) 1g 30

1.50

GM

645

87,922

P

8598M

Oral granules 500mg per sachet 100

1.50

GM

2,134

552,816

P

8599N

Oral granules 1 mg per sachet 100

1.50

GM

18,956

5,592,491

P

8616L

Enemas 2g in 60mL 7

1.50

GM

2,758

918,209

P

8617M

Enemas 4g in 60mL 7

1.50

GM

7,826

3,493,222

INTESTINAL ANTIINFLAMMATORY AGENTS

P

8731M

Tablet 500mg (enteric coated)

1.50

GM

56,113

16,508,377

P

8752P

Suppository 1g 28

1.50

GM

11,087

1,443,267

P

8753Q

Enemas 1g in 100mL 7

1.50

GM

1,257

417,418

P

8768L

Rectal foam 1g per app, 14 apps aerosol 80g 4

1.50

GM

1,679

553,061

P

9206M

Sachet containing granules 1.5g per sachet

1.50

GM

8,111

2,059,647

P

9353G

Tablet 1.2g (prolonged release) 60

1.50

GM

10,559

2,723,348

A07EC03

OLSALAZINE SODIUM

P

1728Y

Capsule 250mg

1.00

GM

4,553

374,744

P

8086N

Capsule 500mg

1.00

GM

12,875

1,651,153

A07EC01

SULPHASALAZINE

P

2093E

Tablet 500mg

2.00

GM

25,483

1,272,506

P

2096H

Tablet 500mg (enteric coated)

2.00

GM

192,262

10,447,065

P

9208P

Tablet 500mg 200

2.00

GM

1,182

59,224

P

9209Q

Tablet 500mg (enteric coated) 200

2.00

GM

7,373

399,311

back to top

A08 - ANTIOBESITY PREPARATIONS EXCL DIET PRODUCTS
2011
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)

ALIMENTARY TRACT AND METABOLISM
ANTIOBESITY PREPARATIONS EXCL DIET PRODUCTS
ANTIOBESITY PREPARATIONS EXCL DIET PRODUCTS
CENTRALLY ACTING ANTIOBESITY PRODUCTS

A08AA01

PHENTERMINE

A

10636

Capsule 15mg 30

15.00

MG

19,752

-

A

10637

Capsule 30mg 30

15.00

MG

84,886

-

A

10638

Capsule 40mg 30

15.00

MG

63,180

-

A

20783

Capsule 15mg 30

15.00

MG

315

-

A

20784

Capsule 30mg 30

15.00

MG

45,427

-

A

20785

Capsule 40mg 30

15.00

MG

35,465

-

PERIPHERALLY ACTING ANTIOBESITY PRODUCTS

A08AB01

ORLISTAT

A

18494

Capsule 120mg 84

0.36

GM

1,059

-

P

4570M

Capsule 120mg 84

0.36

GM

2,186

306,670

back to top

A09 - DIGESTIVES INCL ENZYMES
2011
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)

ALIMENTARY TRACT AND METABOLISM
DIGESTIVES INCL ENZYMES
DIGESTIVES INCL ENZYMES
ENZYME PREPARATIONS

A09AA02

PANCREATIC EXTRACT

P

5453B

Granules (enteric coated) providing not less than 5000 BP units of lipase activity per 100mg 20g 3

-

-

1,486

205,267

P

5454C

Granules (enteric coated) providing not less than 5000 units of lipase activity per 100mg 20g 3

-

-

361

48,046

P

8020D

Capsule (containing enteric coated microspheres) provided not less than 10,000 BP units of lipase activity

-

-

24,520

4,065,209

P

8021E

Capsule (containing enteric coated microspheres) provided not less than 25,000 BP units of lipase activity

-

-

35,922

5,742,153

P

8556H

Capsule (containing enteric coated microspheres) provided not less than 5,000 BP units of lipase activity

-

-

727

77,875

P

9225M

Capsule (containing enteric coated microspheres) provided not less than 5,000 BP units of lipase activity

-

-

120

13,623

P

9226N

Capsule (containing enteric coated microspheres) provided not less than 10,000 BP units of lipase activity

-

-

4,673

744,517

P

9227P

Capsule (containing enteric coated microspheres) provided not less than 25,000 BP units of lipase activity

-

-

6,338

876,091

P

9229R

Capsule (containing enteric coated microspheres) provided not less than 25,000 BP units of lipase activity

-

-

355

52,034

P

9412J

Capsule (containing enteric coated microspheres) provided not less than 40000 BP units of lipase activity 200

-

-

7,499

1,747,784

P

9413K

Capsule (containing enteric coated microspheres) provided not less than 40000 BP units of lipase activity 200

-

-

1,410

297,844

A09AA02

PANCRELIPASE

P

8366H

Capsule (containing enteric coated microspheres) provided not less than 25,000 BP units of lipase activity

-

-

2,666

376,273

back to top

A10 - ANTIDIABETIC THERAPY
2011
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)

ALIMENTARY TRACT AND METABOLISM
ANTIDIABETIC THERAPY
INSULINS AND ANALOGUES
INSULINS AND ANALOGUES FAST-ACTING

A10AB02

INSULIN (BEEF)

P

1713E

Injection 100 units per mL 10mL

40.00

IE

341

58,302

A10AB01

INSULIN (HUMAN)

P

1531N

Injection 100 units per mL 10mL

40.00

IE

8,279

1,064,135

P

1762R

Injection 100 units per mL 3mL 5

40.00

IE

19,408

4,149,325

A10AB05

INSULIN ASPART

P

8435Y

Injection (human) 100 units per mL 3mL 5

40.00

IE

173,524

44,839,686

P

8571D

Injection (human) 100 units per mL 10mL 5

40.00

IE

12,572

1,982,742

A10AB06

INSULIN GLULISINE

P

1921D

Injection (human) 100 units per mL 3mL 5

40.00

IE

13,168

3,440,179

P

9224L

Injection (human) 100 units per mL 10mL 5

40.00

IE

226

33,547

A10AB04

INSULIN LISPRO

P

8084L

Injection 100 units per mL 10mL

40.00

IE

6,744

1,073,498

P

8212F

Injection 100 units per mL 3mL 5

40.00

IE

35,333

9,245,371

INSULINS AND ANALOGUES INTERMEDIATE-ACTING

A10AC02

INSULIN (BEEF)

P

1711C

Injection 100 units per mL 10mL

40.00

IE

576

98,278

A10AC01

INSULIN (HUMAN)

P

1533Q

Injection 100 units per mL 10mL

40.00

IE

13,171

1,757,778

P

1761Q

Injection 100 units per mL 3mL 5

40.00

IE

38,729

8,366,065

INSULINS AND ANALOGUES INTERMEDIATE ACTING COMBINED WITH FAST-ACTING

A10AD01

INSULIN (HUMAN)

P

1426C

Injection 100 units per ml (30 units-70 units)

40.00

IE

1,767

237,644

P

1763T

Injection 100 units per mL (30 units-70 units)

40.00

IE

76,985

17,041,449

P

2062M

Injection 100 units per mL (50 units-50 units)

40.00

IE

3,644

804,588

A10AD30

INSULIN ASPART/PROTAMINE ASPART

P

8609D

Injection (human analogue) 30/70 units per mL

40.00

IE

155,105

40,439,920

A10AD04

INSULIN LISPRO

P

8390N

Injection (human analogue) 100 units per mL 3mL 5

40.00

IE

18,198

4,774,672

P

8874C

Inj (human analogue) 100 units(50/50)per mL 3mL 5

40.00

IE

5,516

1,448,982

INSULINS AND ANALOGUES LONG-ACTING

A10AE05

INSULIN DETEMIR

P

9040T

Injection 100 units per mL 3mL 5

40.00

IE

35,829

15,343,456

A10AE04

INSULIN GLARGINE

A

18353

Injection 100 units per mL 10mL

40.00

IE

547

-

P

9039R

Injection 100 units per mL 3mL 5

40.00

IE

257,833

109,484,665

ORAL BLOOD GLUCOSE LOWERING DRUGS

BIGUANIDES

A10BA02

METFORMIN HYDROCHLORIDE

P

1801T

Tablet 850mg

2.00

GM

301,591

3,942,179

A

21261

Tablet 500mg (extended release) 90

2.00

GM

179

-

P

2430X

Tablet 500mg

2.00

GM

1,290,364

16,460,656

P

3439B

Tablet 1g (extended release) 60

2.00

GM

381,603

6,308,162

P

8607B

Tablet 1000mg

2.00

GM

1,215,949

21,139,343

P

9435N

Tablet 500mg (extended release) 120

2.00

GM

1,335,037

21,964,663

SULFONAMIDES UREA DERIVATIVES

A10BB01

GLIBENCLAMIDE

P

2939Q

Tablet 5mg

10.00

MG

83,450

952,196

A10BB09

GLICLAZIDE

P

2449X

Tablet 80mg 100

60.00

MG

257,742

3,390,924

P

8535F

Tablet 30mg (modified release) 100

60.00

MG

355,405

4,722,109

P

9302N

Tablet 60mg (modified release) 60

60.00

MG

1,222,829

17,969,372

A10BB12

GLIMEPIRIDE

P

8450R

Tablet 1mg 30

2.00

MG

55,024

494,304

P

8451T

Tablet 2mg 30

2.00

MG

76,430

866,163

P

8452W

Tablet 4mg 30

2.00

MG

203,107

2,895,328

P

8533D

Tablet 3mg 30

2.00

MG

29,316

372,847

A10BB07

GLIPIZIDE

P

2440K

Tablet 5mg 100

10.00

MG

55,571

659,949

BIGUANIDES AND SULFONAMIDES IN COMBINATION

A10BD02

METFORMIN and SULFONAMIDES

P

8811R

Tablet 500mg-5mg 90

-

-

79,548

1,346,722

P

8838E

Tablet 250mg-1.25 90

-

-

2,613

34,572

A10BD02

METFORMIN with GLIBENCLAMIDE

P

8810Q

Tablet 500mg-2.5mg 90

-

-

37,576

583,115

A10BD08

METFORMIN with VILDAGLIPTIN

P

5474D

Tablet containing 50mg vildagliptin with 500mg metformin hydrochloride 60

-

-

7,646

747,607

P

5475E

Tablet containing 50mg vildagliptin with 850mg metformin hydrochloride 60

-

-

4,723

472,876

P

5476F

Tablet containing 50mg vildagliptin with 1000mg metformin hydrochloride 60

-

-

28,310

2,862,831

A10BD03

ROSIGLITAZONE with METFORMIN

P

9059T

Tablet 2mg(base)-500mg 56

-

-

3,864

255,969

P

9060W

Tablet 2mg(base)-1000mg 56

-

-

10,137

696,089

P

9061X

Tablet 4mg(base)-500mg 56

-

-

3,748

356,282

P

9062Y

Tablet 4mg(base)-1000mg 56

-

-

19,508

1,915,157

A10BD07

SITAGLIPTIN with METFORMIN

P

9449H

Tablet 50mg (as phosphate monohydrate) - 500mg 56

-

-

51,057

4,835,444

P

9450J

Tablet 50mg (as phosphate monohydrate) - 850mg 56

-

-

33,118

3,213,666

P

9451K

Tablet 50mg (as phosphate monohydrate) - 1000mg 56

-

-

190,807

18,618,892

ALPHA GLUCOSIDASE INHIBITORS

A10BF01

ACARBOSE

P

8188Y

Tablet 50mg

0.30

GM

27,471

863,688

P

8189B

Tablet 100mg

0.30

GM

23,691

1,008,487

THIAZOLIDINEDIONES

A10BG03

PIOGLITAZONE HYDROCHLORIDE

P

8694N

Tablet 15mg (base) 28

30.00

MG

83,898

4,628,526

ORAL BLOOD GLUCOSE LOWERING DRUGS

P

8695P

Tablet 30mg (base) 28

30.00

MG

225,166

18,238,325

P

8696Q

Tablet 45mg (base) 28

30.00

MG

143,160

14,753,594

A10BG02

ROSIGLITAZONE

P

8689H

Tablet 4mg (base) 28

6.00

MG

19,484

1,237,488

P

8690J

Tablet 8mg (base) 28

6.00

MG

20,513

1,885,801

DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS

A10BH03

SAXAGLIPTIN

P

8983T

Tablet 5mg (as hydrochloride) 28

5.00

MG

13,430

1,225,196

A10BH01

SITAGLIPTIN

P

9180E

Tablet 25mg (as phosphate monohydrate) 28

0.10

GM

23,219

2,138,362

P

9181F

Tablet 50mg (as phosphate monohydrate) 28

0.10

GM

64,853

5,974,761

P

9182G

Tablet 100mg (as phosphate monohydrate) 28

0.10

GM

270,711

24,720,021

A10BH02

VILDAGLIPTIN

P

3415R

Tablet 50mg 60

0.10

GM

59,648

5,795,595

OTHER BLOOD GLUCOSE LOWERING DRUGS

A10BX04

EXENATIDE

P

3423E

Injection solution 5ug per dose in pre-filled pen 60 doses 1

0.02

MG

17,448

3,082,452

P

3424F

Injection solution 10ug per dose in pre-filled pen 60 doses 1

0.02

MG

39,570

6,982,641

A10BX02

REPAGLINIDE

A

16646

Tablet 1mg 90

6.00

MG

263

-

A

16647

Tablet 2mg 90

6.00

MG

1,053

-

back to top

A11 - VITAMINS
2011
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)

ALIMENTARY TRACT AND METABOLISM
VITAMINS
VITAMIN A AND D INCL COMBINATIONS OF THE TWO
VITAMIN A PLAIN

A11CA01

VITAMIN A

A

12182

Capsule 50 000 units 100

50.00

TE

521

-

VITAMIN D AND ANALOGUES

A11CC04

CALCITRIOL

P

2502Q

Capsule 0.25ug

1.00

UG

146,883

6,242,866

A11CC01

ERGOCALCIFEROL

A

16060

Capsule 25ug 60

-

-

875,087

-

VITAMIN B1,PLAIN AND IN COMB. WITH VITAMIN B6 AND B12

THIAMINE (VITAMIN B1) PLAIN

A11DA01

THIAMINE HYDROCHLORIDE

P

1070H

Tablet 100mg

50.00

MG

34,951

388,032

P

4043T

Tablet 100mg

50.00

MG

26,066

289,117

VITAMIN B-COMPLEX INCL COMBINATIONS

VITAMIN B-COMPLEX PLAIN

A11EA

VITAMIN B GROUP COMPLEX

P

4493L

Oral liquid 200mL

-

-

10,226

137,042

OTHER PLAIN VITAMIN PREPARATIONS

OTHER PLAIN VITAMIN PREPARATIONS

A11HA02

PYRIDOXINE HYDROCHLORIDE

A

11648

Tablet 25mg 100

160.00

MG

2,068

-

A

11649

Tablet 100mg 50

160.00

MG

1,403

-

OTHER VITAMIN PRODUCTS COMBINATIONS

VITAMINS WITH MINERALS

A11JB

VITAMINS with MINERALS

A

12947

Capsule 100

-

-

140

-

back to top

A12 - MINERAL SUPPLEMENTS
2011
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)

ALIMENTARY TRACT AND METABOLISM
MINERAL SUPPLEMENTS
CALCIUM
CALCIUM

A12AA04

CALCIUM CARBONATE

A

20271

Tablet 600mg (as carbonate) 120

3.00

GM

43,767

-

P

3116B

Tablet (chewable) 500mg (as carbonate)

3.00

GM

15,098

427,794

P

3117C

Tablet 600mg (as carbonate) 240

3.00

GM

4,121

76,528

P

4082W

Tablet (chewable) 600mg (as carbonate) 120

3.00

GM

8,122

115,793

P

4094L

Tablet (chewable) 500mg (as carbonate)

3.00

GM

1,817

50,532

P

4142B

Tablet 600mg (as carbonate) 240

3.00

GM

1,179

24,742

P

4333C

Tablet (chewable) 500mg (as carbonate) 120

3.00

GM

5,613

102,439

A12AA

CALCIUM CITRATE

A

20956

Tablet 250mg (as citrate) 120

-

-

1,313

-

CALCIUM, COMBINATIONS WITH VITAMIN D AND/OR OTHER DRUGS

A12AX

CALCIUM CARBONATE with CHOLECALCIFEROL

A

10600

Tablet 600mg 60

3.00

13,490

-

POTASSIUM

POTASSIUM

A12BA01

POTASSIUM CHLORIDE

P

2642C

Tablet 600mg (sustained release)

3.00

GM

297,926

3,751,387

P

3012M

Effervescent tabs 14mmol K,8mmol Cl ions

3.00

GM

31,396

494,148

OTHER MINERAL SUPPLEMENTS

ZINC

A12CB01

ZINC SULPHATE

A

12264

Capsule 50mg 100

0.60

GM

303

-

MAGNESIUM

A12CC05

MAGNESIUM ASPARTATE

A

11226

Tablet 100

-

-

2,322

-

P

4321K

Tablet 37.4mg (as aspartate dihydrate)

-

-

49,265

808,311

back to top

A14 - ANABOLIC AGENTS FOR SYSTEMIC USE
2011
ATC ITEM TYPE CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($)

ALIMENTARY TRACT AND METABOLISM
ANABOLIC AGENTS FOR SYSTEMIC USE
ANABOLIC STEROIDS
ESTREN DERIVATIVES

A14AB01

NANDROLONE DECANOATE

P

1671Y

Injection 50mg in 1mL disposable syringe

2.00

MG

4,552

102,291

back to top